Sustainability

Sustainability

ESG Rules

Release Date: 2023-06-09

Sino Biopharm adheres to the mission of "improving the quality of life and protecting the dignity of human life" and the values of " Integrity, Foresight, Innovation, Commitment, Efficiency, Collaboration". We are committed to practicing the natural mission of pharmaceutical people to the society and the industry, and seeking well-being for a broader range of patients through continuous high-level innovation.


Compliance with Laws and Regulations

Sino Biopharm strictly abides by local laws and regulations, adheres to compliance operation, and is committed to creating a sustainable development model of win-win for enterprises, society and the environment.


Intellectual Property Protection

Driven by innovation and research, Sino Biopharm attaches great importance to intellectual property protection. At the same time, we respect the intellectual property rights (IPR) of any third party in order to promote the healthy development of the industry's R&D environment. We have formulated IPR related management systems and standardized related management work.


Quality and Safety Management

Sino Biopharm regards product quality and safety as the lifeline of the enterprise. We build a quality assurance system covering the whole life cycle of drug research and development, material procurement, production and packaging, storage and transportation, product sales and product after-sales. We regularly carry out internal audit, cooperate with external audit, set high standards for ourselves in the industry, and constantly improve the quality and safety management level and performance. We have formulated quality and safety-related management systems to standardize relevant management work.


Medical Accessibility

Sino Biopharm adheres to the business philosophy of "enabling more patients to obtain drugs and more diseases to be treated", and ensures that patients' needs are the core of drug research and development and industrialization to provide patients with more and more accessible drugs. We believe that continuing to promote access to medicines can bring more stable and sustainable value to the enterprise.


Bioethical Standard

Sino Biopharm adheres to bioethical standards across all research projects. We are committed to alleviating suffering and adhere to the ethics and code of conduct laid down by the regulatory authorities in our research and development.

 

Data Protection and Privacy Security

Sino Biopharm attaches great importance to the information security and privacy protection of customers and partners, and strictly abides by Chinese laws and regulations on information security. We have formulated data and privacy security management measures and employee codes of conduct, requiring all employees to abide by the principle of information confidentiality, and adopt information management mode to control the risk of information disclosure.

Business Ethics and Anti-corruption

Sino Biopharm promises to follow business ethics standards, strictly abide by the relevant national laws and regulations, and have zero tolerance for any form of corruption. We have formulated anti-commercial bribery and whistle-blower protection systems to standardize internal supervision and handling procedures and strengthen business ethics management.

Environmental Protection

Sino Biopharm adheres to the concept of green development and is committed to building an environment-friendly enterprise. We adhere to compliance with emissions and reduce the environmental impact of our operations. We actively promote low-carbon transformation, and work with industrial chain partners to continuously explore and expand the application of renewable energy.
 

Health and Safety

Sino Biopharm is committed to providing employees with a healthy and safe working environment and regards employee health and safety as the premise of production and operation. We firmly abide by the safety production laws and regulations, with strict safety standards to carry out the design, construction and operation management of the production base.
 

Employee Rights and Interests Protection

Sino Biopharm firmly protects the legitimate rights and interests of its employees, forbids the use of child labor and all forms of harassment or forced labor. We promise not to discriminate against or treat employees differently based on their nationality, ethnicity, place of origin, gender, age, physical characteristics, hobbies, or religious beliefs. We respect the rights and interests of female employees, formulate policies on maternity leave, breast-feeding leave and parental leave, and create and build a safe, healthy and belonging working environment for female employees. We have formulated employee handbook and other systems to standardize related management. Our employees are entitled to nursing leave in accordance with the law. At the same time, we provide flexible working hours for employees. Employees can decide their working hours within a certain range on the basis of ensuring the working hours stipulated by the labor law. We believe this helps employees better balance their work and personal lives.
 

Talent Attraction and Development

Sino Biopharm adheres to the people-oriented principle, regards employees as the cornerstone of the company's longevity, and looks forward to sharing development achievements with employees and creating a better future together. We are committed to providing employees with competitive compensation and benefits within the industry and region. We continuously build a high-quality talent team and constantly improve employee career training and development paths. We value employees' opinions and constantly improve employee satisfaction.
 

Diversity and Inclusion

Sino Biopharm is committed to building a diversified and inclusive corporate culture. We believe that a diverse talent team can create more constructive ideas, and an equal and inclusive working environment can inspire more positive work enthusiasm.
 

Materiality Assessment
We communicate regularly or irregularly with stakeholders, including government and industry regulators, investors, customers, suppliers, employees, communities, etc., through a variety of channels to understand their expectations and opinions on the Group's ESG performance. We fully consider the opinions of stakeholders in our daily operational decisions and take timely action to respond to their demands. Based on stakeholder communication and external expert opinions, we review and reassess the ESG materiality issue matrix at least once a year; and conduct extensive special surveys of stakeholders once every three years. The Board of Directors reviews and supervises the results of the ESG materiality assessment at least once a year.
 

Donation Activities
We do not make any form of direct or indirect political donations. Our charitable donations are for the purpose of supporting public benefit, disaster relief, rural revitalisation and inclusive healthcare, and involve no corruption means.

 

Sino Biopharm sets high standards for its ESG management, adhere to them, and integrate them throughout the company's operations. We prohibit all forms of violation of the management system, and establish a corresponding punishment mechanism. We firmly believe that our values can guide us to always do the right thing and achieve long-term value in a complex and changing environment.

Share: